UPDATE: Teva Pharma (TEVA) Misses Q3 EPS by 4c, Q4 Guidance Comes in Light

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. EXPE
3. ARM
4. FIS
5. BROS
6. DDOG
7. QCOM
8. ZG
9. EW
10. CPAY

Go back to UPDATE: Teva Pharma (TEVA) Misses Q3 EPS by 4c, Q4 Guidance Comes in Light

Teva Pharma (TEVA) PT Lowered to $14 at Susquehanna

November 6, 2017 7:25 AM EST

Susquehanna lowered its price target on Teva Pharma (NYSE: TEVA) to $14.00 (from $20.00) while maintaining a Positive rating.

Analyst Andrew Finkelstein notes Q3 showed further challenges.

... More

Teva Pharma (TEVA) PT Slashed to $10 at Cantor Fitzgerald

November 2, 2017 1:39 PM EDT

Cantor Fitzgerald analyst Louise Chen lowered her price target on Teva Pharma (NYSE: TEVA) to $10.00 (from $17.00) while maintaining a Neutral rating following Q3 miss and lower guide.

Chen thinks the company has some meaningful headwinds which need to be addressed before the... More

Teva Pharma (TEVA) Plunges to Fresh Low, Down 16%

November 2, 2017 9:33 AM EDT

Teva Pharma (NYSE: TEVA) Plunges to Fresh Low, Down 16%

... More